Linolenic acid ethyl esterCAS# 1191-41-9 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 1191-41-9 | SDF | Download SDF |
PubChem ID | 5367460 | Appearance | Liquid |
Formula | C20H34O2 | M.Wt | 306.48 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | ethyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate | ||
SMILES | CCC=CCC=CCC=CCCCCCCCC(=O)OCC | ||
Standard InChIKey | JYYFMIOPGOFNPK-AGRJPVHOSA-N | ||
Standard InChI | InChI=1S/C20H34O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22-4-2/h5-6,8-9,11-12H,3-4,7,10,13-19H2,1-2H3/b6-5-,9-8-,12-11- | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Linolenic acid ethyl ester Dilution Calculator
Linolenic acid ethyl ester Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.2629 mL | 16.3143 mL | 32.6286 mL | 65.2571 mL | 81.5714 mL |
5 mM | 0.6526 mL | 3.2629 mL | 6.5257 mL | 13.0514 mL | 16.3143 mL |
10 mM | 0.3263 mL | 1.6314 mL | 3.2629 mL | 6.5257 mL | 8.1571 mL |
50 mM | 0.0653 mL | 0.3263 mL | 0.6526 mL | 1.3051 mL | 1.6314 mL |
100 mM | 0.0326 mL | 0.1631 mL | 0.3263 mL | 0.6526 mL | 0.8157 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Phellolactone
Catalog No.:BCN3467
CAS No.:1190897-23-4
- Fluorobexarotene
Catalog No.:BCC6110
CAS No.:1190848-23-7
- Fmoc-Asp-OH
Catalog No.:BCC3085
CAS No.:119062-05-4
- Euchrenone B1
Catalog No.:BCN3575
CAS No.:119061-09-5
- MRT67307
Catalog No.:BCC1779
CAS No.:1190378-57-4
- EB 47
Catalog No.:BCC2452
CAS No.:1190332-25-2
- PSI-7976
Catalog No.:BCC5138
CAS No.:1190308-01-0
- PSI-7977
Catalog No.:BCC1871
CAS No.:1190307-88-0
- Sarcandrone B
Catalog No.:BCN6074
CAS No.:1190225-48-9
- Sarcandrone A
Catalog No.:BCN6073
CAS No.:1190225-47-8
- M2 ion channel blocker
Catalog No.:BCC1726
CAS No.:1190215-03-2
- 4-[2-[(3-Ethyl-4-methyl-2-oxo-3-pyrrolin-1-yl)carboxamido]ethyl]benzenesulfonamide
Catalog No.:BCC8672
CAS No.:119018-29-0
- 1-Acetoxy-5-deacetylbaccatin I
Catalog No.:BCN6357
CAS No.:119120-27-3
- IOWH-032
Catalog No.:BCC3922
CAS No.:1191252-49-9
- Ganomycin I
Catalog No.:BCN3504
CAS No.:1191255-15-8
- B-Raf inhibitor 1 dihydrochloride
Catalog No.:BCC4183
CAS No.:1191385-19-9
- 3-Oxosapriparaquinone
Catalog No.:BCN3153
CAS No.:119139-56-9
- Glychionide A
Catalog No.:BCN3250
CAS No.:119152-50-0
- Coronarin A
Catalog No.:BCN6075
CAS No.:119188-33-9
- Coronarin D
Catalog No.:BCN6076
CAS No.:119188-37-3
- Coronarin B
Catalog No.:BCN6077
CAS No.:119188-38-4
- 10-Hydroxyscandine
Catalog No.:BCN6078
CAS No.:119188-47-5
- CZC-25146
Catalog No.:BCC5371
CAS No.:1191911-26-8
- CZC 54252 hydrochloride
Catalog No.:BCC6218
CAS No.:1191911-27-9
Remarkably high inhibitory effects of docosahexaenoic acid incorporated into hybrid liposomes on the growth of tumor cells along with apoptosis.[Pubmed:18511224]
Int J Pharm. 2008 Jul 9;359(1-2):264-71.
Inhibitory effects of hybrid liposomes composed of l-alpha-dimyristoylphosphatidylcholine (DMPC) and polyoxyethylene (20) sorbitan monooleate (Tween 80) including polyunsaturated fatty acids or their ethyl esters (HL-PUFA) on the growth of human tumor cells were examined in vitro. Remarkably high inhibitory effects of HL including docosahexaenoic acid (HL-DHA) and alpha-Linolenic acid ethyl ester (HL-ALAE) on the growth of lung carcinoma (RERF-LC-OK and A549) cells, colon tumor (WiDr) cells and stomach tumor (MKN45) cells were obtained. The addition of vitamin E (alpha-tocopherol) to HL-DHA and -ALAE prevented almost completely the growth inhibition of A549 cells distinct from the other tumor cells used in this study. On the other hand, fluorescence microscopic and flow cytometric analyses indicated that the inhibitory effects of HL-DHA on the growth of RERF-LC-OK, WiDr and MKN45 cells could be attained through the induction of apoptosis.